BioSpace News Archive

BioMidwest

Centene Selected For Statewide Medicaid Contract And Statewide Specialty Children’s Plan Contract In Oklahoma

Centene Corporation announced that its Oklahoma subsidiary, Oklahoma Complete Health, has been selected by the Oklahoma Health Care Authority for statewide contracts to provide managed care for the SoonerSelect and SoonerSelect Specialty Children’s Plan programs.

February 1, 2021

·

11 min read

Magnetoencephalography Market Detailed Analysis and Forecast by 2030

The rising prevalence of mental illnesses and depression cases, coupled with the increasing awareness about the same is expected to aid in expansion of the global magnetoencephalography market during the forecast period, 2020 to 2030.

February 1, 2021

·

3 min read

Smart Hospitals Market Review Report with Forecast by 2030

The increasing adoption of latest technology for medical therapeutic applications worldwide will help boost the growth of the global smart hospitals market during the forecast period, 2020 to 2030.

February 1, 2021

·

4 min read

Vitamin D Testing Market | Increasing incidences of disorders related to vitamin D deficiency drive market growth

Deficiency of Vitamin D is a common issue faced by many across the globe. It is more common amongst the older adults.

February 1, 2021

·

4 min read

Drug Development

Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate

The Coalition for Epidemic Preparedness Innovations (CEPI) continues to support Clover’s COVID-19 vaccine candidate and will fund its development through licensure.

February 1, 2021

·

8 min read

Genetown

Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration with Metrion Biosciences

Collaboration combines Sosei Heptares’ leading structure-based drug design platform with Metrion Biosciences’ ion channel expertise

February 1, 2021

·

6 min read

New Scientific Publications Show Diadem’s Blood-Based AlzoSure® Biomarker Test Can Predict Which Patients Will Progress to Alzheimer’s Disease Years Before Symptoms Occur

Published Studies Explore How a Variant of p53 Contributes to the Development of Alzheimer’s Disease (AD) and How Plasma Levels of this Variant Can Serve as a Prognostic Biomarker Predicting Progression to AD Early in the Disease Process

February 1, 2021

·

11 min read

Biotech Bay

Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution Now Available in Germany for the Treatment of Seizures in Dravet Syndrome

FINTEPLA offers a new treatment option for patients in Germany with Dravet syndrome, a rare, devastating, infant-onset epilepsy marked by frequent seizures, medical emergencies, and developmental impairments

February 1, 2021

·

6 min read

Deals

Lexaria Provides Guidance on Upcoming R&D

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announces applied R&D programs to begin immediately.

February 1, 2021

·

8 min read

Pharm Country

Merck Receives Positive EU CHMP Opinion for Expanded Approval of KEYTRUDA® (pembrolizumab) in Certain Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of an expanded label for KEYTRUDA, Merck’s anti-PD-1 therapy

February 1, 2021

·

38 min read